MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis.

ABSTRACT: Metabolic profiling of cancer cells has recently been established as a promising tool for the development of therapies and identification of cancer biomarkers. Here we characterized the metabolomic profile of human breast tumors and uncovered intrinsic metabolite signatures in these tumors using an untargeted discovery approach and validation of key metabolites. The oncometabolite 2-hydroxyglutarate (2HG) accumulated at high levels in a subset of tumors and human breast cancer cell lines. We discovered an association between increased 2HG levels and MYC pathway activation in breast cancer, and further corroborated this relationship using MYC overexpression and knockdown in human mammary epithelial and breast cancer cells. Further analyses revealed globally increased DNA methylation in 2HG-

SUBMITTER: Terunuma A 

PROVIDER: S-EPMC3871244 | biostudies-literature | 2014 Jan

REPOSITORIES: biostudies-literature